Laura Chico
Stock Analyst at Wedbush
(4.68)
# 781
Out of 5,081 analysts
650
Total ratings
49.1%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Laura Chico
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CLYM Climb Bio | Reiterated: Buy | $20 → $25 | $8.81 | +183.77% | 8 | Oct 26, 2026 | |
| VERA Vera Therapeutics | Reiterated: Hold | $34 | $28.30 | +20.14% | 15 | Oct 23, 2026 | |
| BIIB Biogen | Reiterated: Hold | $215 → $212 | $252.26 | -15.96% | 70 | Oct 19, 2026 | |
| OVID Ovid Therapeutics | Reiterated: Buy | $7 | $2.16 | +224.83% | 14 | Oct 8, 2026 | |
| KRSA Korsana Biosciences | Initiated Coverage: Buy | $44 | $32.09 | +37.11% | 1 | Oct 5, 2026 | |
| EWTX Edgewise Therapeutics | Reiterated: Buy | $52 → $53 | $39.17 | +35.31% | 24 | Sep 23, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $48 | $31.07 | +54.49% | 8 | Sep 23, 2026 | |
| TVTX Travere Therapeutics | Reiterated: Buy | $75 → $76 | $49.97 | +52.09% | 36 | Sep 22, 2026 | |
| RARE Ultragenyx Pharmaceutical | Reiterated: Hold | $23 | $16.08 | +43.03% | 58 | Sep 18, 2026 | |
| XENE Xenon Pharmaceuticals | Reiterated: Buy | $63 → $55 | $35.77 | +53.76% | 20 | Sep 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 → $6 | $3.69 | +62.60% | 5 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $42 → $50 | $31.54 | +58.53% | 9 | Sep 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $9 | $3.00 | +200.00% | 21 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $9.15 | +774.32% | 8 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $47 | $14.50 | +224.14% | 12 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $20 | $7.88 | +153.81% | 17 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $43 → $41 | $23.34 | +75.66% | 74 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $105 → $122 | $79.33 | +53.79% | 16 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 → $11 | $2.24 | +391.07% | 9 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $185 → $194 | $145.87 | +33.00% | 25 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 → $26 | $18.66 | +39.34% | 27 | Jul 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $166 → $162 | $267.39 | -39.41% | 24 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 → $16 | $5.81 | +175.39% | 8 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $21 → $24 | $22.11 | +8.55% | 10 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 → $4 | $2.49 | +60.64% | 13 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $38 | $25.46 | +49.25% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $11.44 | +249.65% | 2 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $8 → $7 | $1.75 | n/a | 10 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $13 → $11 | $16.65 | n/a | 4 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $5 | $10.34 | n/a | 8 | Mar 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $5 | $4.01 | n/a | 5 | Aug 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $3.36 | n/a | 4 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $3 → $45 | $0.5102 | n/a | 5 | Aug 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $55.75 | n/a | 15 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $517.49 | n/a | 16 | Jan 2, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $7.28 | n/a | 10 | Sep 12, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $1.22 | n/a | 4 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $807.67 | n/a | 16 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $3.99 | n/a | 1 | Jan 18, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.152 | n/a | 1 | Jan 4, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $61.90 | n/a | 1 | Dec 7, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $0.8421 | n/a | 1 | Jun 30, 2017 |
Climb Bio
Oct 26, 2026
Reiterated: Buy
Price Target: $20 → $25
Current: $8.81
Upside: +183.77%
Vera Therapeutics
Oct 23, 2026
Reiterated: Hold
Price Target: $34
Current: $28.30
Upside: +20.14%
Biogen
Oct 19, 2026
Reiterated: Hold
Price Target: $215 → $212
Current: $252.26
Upside: -15.96%
Ovid Therapeutics
Oct 8, 2026
Reiterated: Buy
Price Target: $7
Current: $2.16
Upside: +224.83%
Korsana Biosciences
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $44
Current: $32.09
Upside: +37.11%
Edgewise Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $52 → $53
Current: $39.17
Upside: +35.31%
Maze Therapeutics
Sep 23, 2026
Reiterated: Buy
Price Target: $48
Current: $31.07
Upside: +54.49%
Travere Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $75 → $76
Current: $49.97
Upside: +52.09%
Ultragenyx Pharmaceutical
Sep 18, 2026
Reiterated: Hold
Price Target: $23
Current: $16.08
Upside: +43.03%
Xenon Pharmaceuticals
Sep 18, 2026
Reiterated: Buy
Price Target: $63 → $55
Current: $35.77
Upside: +53.76%
Sep 15, 2026
Reiterated: Hold
Price Target: $5 → $6
Current: $3.69
Upside: +62.60%
Sep 9, 2026
Reiterated: Buy
Price Target: $42 → $50
Current: $31.54
Upside: +58.53%
Aug 18, 2026
Reiterated: Buy
Price Target: $19 → $9
Current: $3.00
Upside: +200.00%
Aug 14, 2026
Reiterated: Hold
Price Target: $80
Current: $9.15
Upside: +774.32%
Aug 11, 2026
Reiterated: Buy
Price Target: $47
Current: $14.50
Upside: +224.14%
Aug 6, 2026
Reiterated: Buy
Price Target: $21 → $20
Current: $7.88
Upside: +153.81%
Aug 6, 2026
Reiterated: Buy
Price Target: $43 → $41
Current: $23.34
Upside: +75.66%
Aug 5, 2026
Reiterated: Buy
Price Target: $105 → $122
Current: $79.33
Upside: +53.79%
Aug 5, 2026
Reiterated: Buy
Price Target: $12 → $11
Current: $2.24
Upside: +391.07%
Aug 3, 2026
Reiterated: Buy
Price Target: $185 → $194
Current: $145.87
Upside: +33.00%
Jul 13, 2026
Reiterated: Buy
Price Target: $23 → $26
Current: $18.66
Upside: +39.34%
Jun 2, 2026
Reiterated: Sell
Price Target: $166 → $162
Current: $267.39
Upside: -39.41%
May 18, 2026
Reiterated: Buy
Price Target: $17 → $16
Current: $5.81
Upside: +175.39%
May 14, 2026
Reiterated: Hold
Price Target: $21 → $24
Current: $22.11
Upside: +8.55%
May 13, 2026
Reiterated: Buy
Price Target: $5 → $4
Current: $2.49
Upside: +60.64%
May 8, 2026
Reiterated: Buy
Price Target: $38
Current: $25.46
Upside: +49.25%
May 7, 2026
Reiterated: Buy
Price Target: $40
Current: $11.44
Upside: +249.65%
Aug 7, 2024
Reiterated: Hold
Price Target: $8 → $7
Current: $1.75
Upside: n/a
Apr 11, 2024
Reiterated: Buy
Price Target: $13 → $11
Current: $16.65
Upside: n/a
Mar 20, 2024
Reiterated: Hold
Price Target: $5
Current: $10.34
Upside: n/a
Aug 12, 2022
Reiterated: Buy
Price Target: $22 → $5
Current: $4.01
Upside: n/a
Feb 11, 2022
Reiterated: Buy
Price Target: $23
Current: $3.36
Upside: n/a
Aug 11, 2020
Reiterated: Hold
Price Target: $3 → $45
Current: $0.5102
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $55.75
Upside: n/a
Jan 2, 2019
Downgraded: Hold
Price Target: n/a
Current: $517.49
Upside: n/a
Sep 12, 2018
Downgraded: Hold
Price Target: n/a
Current: $7.28
Upside: n/a
Aug 13, 2018
Reiterated: Hold
Price Target: n/a
Current: $1.22
Upside: n/a
Aug 8, 2018
Reiterated: Hold
Price Target: n/a
Current: $807.67
Upside: n/a
Jan 18, 2018
Initiated Coverage: Buy
Price Target: $24
Current: $3.99
Upside: n/a
Jan 4, 2018
Reiterated: Hold
Price Target: n/a
Current: $0.152
Upside: n/a
Dec 7, 2017
Reiterated: Buy
Price Target: n/a
Current: $61.90
Upside: n/a
Jun 30, 2017
Reiterated: Buy
Price Target: $30
Current: $0.8421
Upside: n/a